COTRIMOXAZOLE, 200mg/40mg/5ml, oral susp, 100ml, bot.
NST
DORACOTR2S1
Valid Article
HS Code:
300420
Last Updated on:
07/11/2024, 20:40:01
Former
Code(s):
-X DORACOTR004 DORAZBE0004
6.2.1 - Access group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
6.5.4 - Antipneumocystosis and antitoxoplasmosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01EE01
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
COTRIMOXAZOLE (CTX)
Full Name
sulfamethoxazole (SMX) + trimethoprim (TMP)
Therapeutic Action
Combination of two antibacterials: a sulfonamide (sulfamethoxazole) and a diaminopyrimidine antifolate (trimethoprim)
Indications
Cerebral toxoplasmosis, pneumocystosis, isosporiasis, cyclosporiasis and brucellosis
Prophylaxis of pneumocystosis, toxoplasmosis and isosporiasis
Second-line treatment of pertussis
Typhoid fever if the strain is susceptible
Instructions for use
The dispersible tablet is intended for paediatric use. It replaces the oral suspension and the 120 mg normal tablet.
Precautions for Use
Do not administer to children under 1 month of age.
Storage
Below 25°C - Protect from sunlight - Protect from humidity
![[DORACOTR1TD] COTRIMOXAZOLE, 100mg/ 20mg, disp. tab.](/web/image/product.template/571982/image_256/%5BDORACOTR1TD%5D%20COTRIMOXAZOLE%2C%20100mg-%2020mg%2C%20disp.%20tab.?unique=aafda66)